Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 905,050 | 895,937 | 914,607 | 824,566 | 790,990 |
| Cost of Goods | 557,938 | 558,710 | 572,586 | 516,288 | 491,022 |
| Gross Profit | 347,112 | 337,227 | 342,021 | 308,278 | 299,968 |
| Operating Expenses | 175,243 | 182,135 | 205,057 | 184,863 | 171,063 |
| Operating Income | 172,807 | 155,802 | 137,550 | 123,703 | 128,927 |
| Interest Expense | 11,546 | 16,455 | 16,190 | 29,719 | 33,147 |
| Other Income | 2,381 | -16,077 | 6,136 | -27,682 | 76,647 |
| Pre-tax Income | 163,642 | 123,270 | 127,496 | 66,302 | 172,427 |
| Income Tax | 23,815 | 18,111 | 37,580 | 2,367 | 28,237 |
| Net Income Continuous | 139,827 | 105,159 | 89,916 | 63,935 | 144,190 |
| Minority Interests | 2,249 | 1,733 | 1,468 | 2,405 | 999 |
| Net Income | $137,578 | $103,426 | $88,448 | $61,530 | $143,191 |
| EPS Basic Total Ops | 2.73 | 2.05 | 1.76 | 1.23 | 2.89 |
| EPS Basic Continuous Ops | 2.78 | 2.09 | 1.79 | 1.28 | 2.91 |
| EPS Diluted Total Ops | 2.67 | 2.01 | 1.72 | 1.20 | 2.81 |
| EPS Diluted Continuous Ops | 2.71 | 2.04 | 1.75 | 1.25 | 2.83 |
| EBITDA(a) | $240,048 | $224,488 | $205,655 | $185,211 | $189,803 |